Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Income from Continuing Operations (2020 - 2025)

RxSight (RXST) has disclosed Income from Continuing Operations for 6 consecutive years, with 29724000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 600.49% year-over-year to 29724000.0, compared with a TTM value of 67000.0 through Dec 2025, up 99.76%, and an annual FY2025 reading of 67000.0, up 99.76% over the prior year.
  • Income from Continuing Operations was 29724000.0 for Q4 2025 at RxSight, up from 9815000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 29724000.0 in Q4 2025 and bottomed at 17596000.0 in Q1 2022.
  • Average Income from Continuing Operations over 5 years is 9579750.0, with a median of 12100500.0 recorded in 2023.
  • The sharpest move saw Income from Continuing Operations plummeted 158.57% in 2022, then surged 600.49% in 2025.
  • Year by year, Income from Continuing Operations stood at 15748000.0 in 2021, then increased by 0.86% to 15613000.0 in 2022, then soared by 41.21% to 9179000.0 in 2023, then soared by 35.3% to 5939000.0 in 2024, then soared by 600.49% to 29724000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RXST at 29724000.0 in Q4 2025, 9815000.0 in Q3 2025, and 11786000.0 in Q2 2025.